Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.
about
Behavior of antibiotics during human necrotizing pancreatitis.The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure.Antimicrobial activity of human pancreatic juice and its interaction with antibiotics.Imipenem concentrations in colorectal surgery and impact on the colonic microflora.Pharmacokinetics of FCE 22891, a new oral penem.Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans.Using imipenem and cilastatin during continuous renal replacement therapy.Human variability in susceptibility to toxic chemicals--a preliminary analysis of pharmacokinetic data from normal volunteers.In vitro and pharmacokinetic properties of the carbapenems.Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of miceRadiolabeled quaternary carbapenems and their interactions with human serum albumin.Cilastatin does not alter superoxide dismutase activity.Determination of imipenem and cilastatin in serum by high-pressure liquid chromatography.Disposition of radiolabeled imipenem and cilastatin in normal human volunteers.Multiple-dose pharmacokinetics of imipenem-cilastatin.Pharmacokinetics of imipenem-cilastatin in neonates.Single-dose pharmacokinetics of imipenem-cilastatin in neonates.Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosisDegradation kinetics of imipenem in normal saline and in human serum.Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors.In vitro activity of MK-7655, a novel β-lactamase inhibitor, in combination with imipenem against carbapenem-resistant Gram-negative bacteria.Imipenem/cilastatin versus gentamicin/clindamycin: a cost effectiveness study.Hydrophilic interaction chromatography/tandem mass spectrometry for the simultaneous determination of three polar non-structurally related compounds, imipenem, cilastatin and an investigational beta-lactamase inhibitor, MK-4698, in biological matricImipenem/cilastatin.
P2860
Q33753205-68845C53-7C53-4B96-B26A-20B0BFF9B919Q34621525-CD98B2E4-DE61-4895-9F57-EF3F311F6807Q35126768-FCF646AD-A303-4A20-93FB-7ACCDB4B32A6Q35244314-A6CE5780-8B94-40DC-A627-F50E77DB47A8Q35258286-299C32B9-3FB6-4E90-8D1D-43DB818FC3B5Q35807561-995BFD97-4410-4231-90AB-1735D758A8FFQ36338191-447D0CBE-94E6-40DC-851D-9A2E10929C84Q36457487-3AAE233F-31DA-41A6-9890-229BCDB4AA2DQ39747565-2F28A131-7BFA-439E-AEA0-1880710634A6Q39817374-24EC10BC-C526-4ADF-9090-38390AB58282Q39817622-21ACDC8F-21A0-4966-8A2E-985E7594393FQ39834286-25238A5E-FBDF-4FE3-96ED-04F67E7ABF4DQ39848938-C9E90204-C549-4955-AAF8-B25E066032F7Q39849271-B63F69F8-1B43-4E29-A019-16C6E712EF82Q39849277-0D457F14-7A20-44AC-ADBE-D84AF144F8B1Q39849539-0FA80BD0-2402-472C-812F-91B0FEC3FC65Q39849620-13E31F91-3AB1-4B67-8561-C5E143167CAFQ39849680-2B3ECAF7-0A75-4A2F-AD08-E750C63FA2D0Q40283679-4C26BF84-E590-4E20-9F22-8482412877C0Q42180547-CFC570D9-1611-4B59-9DF3-37005F0CCA03Q42186280-16F4D4FD-CC41-4CF3-B925-B335B3D024BBQ44419033-B49C7E54-324B-40A1-92E6-00CED576F55CQ45967729-BBA2FDB4-4A3A-421A-BD1B-8C5883620EABQ54467055-CA38F08F-B4DA-4B03-A12C-0452D7A045B0
P2860
Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.
@en
Pharmacokinetics and tolerance of N-formimidoyl thienamycin
@nl
type
label
Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.
@en
Pharmacokinetics and tolerance of N-formimidoyl thienamycin
@nl
prefLabel
Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.
@en
Pharmacokinetics and tolerance of N-formimidoyl thienamycin
@nl
P2093
P2860
P356
P1476
Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.
@en
P2093
Meisinger MA
P2860
P304
P356
10.1128/AAC.23.2.293
P407
P577
1983-02-01T00:00:00Z